From Wikipedia, the free encyclopedia
|Systematic (IUPAC) name|
|Mol. mass||325.404 g/mol|
(what is this?) |
ABT-670 is a drug which acts as a potent, orally bioavailable dopamine agonist selective for the D4 subtype, which was developed as a possible treatment for erectile dysfunction, although its current uses are limited to scientific research.
- Melanotan II
- Patel, MV; Kolasa, T; Mortell, K; Matulenko, MA; Hakeem, AA; Rohde, JJ; Nelson, SL; Cowart, MD et al. (2006). "Discovery of 3-methyl-N-(1-oxy-3',4',5',6'-tetrahydro-2'H-2,4'-bipyridine-1'-ylmethyl)benzamide (ABT-670), an orally bioavailable dopamine D4 agonist for the treatment of erectile dysfunction". Journal of Medical Chemistry 49 (25): 7450–65. doi:10.1021/jm060662k. PMID 17149874.
- Richards N, Wayman C, Allers KA. Electrophysiological actions of the dopamine agonist apomorphine in the paraventricular nucleus during penile erection. Neuroscience Letters. 3 September 2009 doi:10.1016/j.neulet.2009.08.078
|This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by expanding it.|